Skip to content
Blogs
FEATURED | May 1, 2025

Why I’m Getting Naked for Skin Health 

Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...

3 Minute Read
December 20, 2020

Novel Target for Melanoma Therapeutic Development

Melanoma is one of the fastest growing malignancies and accounts for 5.5% of all new cancer cases in the United States. Treatment options and prognosis of melanoma patients...

2 Minute Read
December 20, 2019

Modulating p53 Transcriptional Activity to Reduce ...

Successful management of melanoma will require eliminating both the primary cancer as well as its spread. The survival of melanoma patients reduces significantly if the ...

2 Minute Read
December 20, 2019

Pharmacological Targeting of Estrogen Receptor to ...

The development of new classes of drugs which target pathways required for melanoma growth and approaches to increase tumor immunogenicity (Immune Checkpoint Blockade (ICB)...

3 Minute Read
December 20, 2019

Cellular and Genomic Landscape of Uveal Melanoma a...

Uveal melanoma (UM) is a highly aggressive eye cancer that leads to metastatic death in up to half of patients, with no measurable improvement in survival over the past hal...

2 Minute Read
December 23, 2018

RAC1 Mutant Melanoma: Models and Therapeutics

Description: Many genes have recently been discovered that, when mutated, promote the development of malignant melanoma. Such discoveries are important, as they can point t...

2 Minute Read
December 20, 2018

Inhibiting BRD9 in Melanoma

Melanoma is the most serious type of skin cancer that can spread to other parts of the body, where it becomes difficult to treat and can be fatal. Over half of all melanoma...

2 Minute Read
December 20, 2018

In Vivo Model of Human Melanoma Using a Novel Neur...

Protective mechanisms called “immune evasion” thus making it difficult for immunotherapies to be fully effective and to lead to complete cure. These mechanisms have onl...

3 Minute Read
December 20, 2017

MC1R-selective small melanocortin analogs for mela...

Melanoma is the deadliest form of skin cancer, and despite the exciting advancements in treatment, there is still no cure for late stage disease. The incidence of melanom...

2 Minute Read
December 20, 2017

GPER Signaling in Melanoma

Melanoma immunotherapy works by stimulating immune cells to kill tumor. In many cases, immune cells are drawn to tumor by immunogenic proteins on the surface of tumor ce...

2 Minute Read
December 20, 2017

Targeting Elongation Factor-2 Kinase to Reinforce ...

Melanoma, one of the most aggressive and fatal neoplasms, is responsible for over 80% of skin cancer-related deaths. As melanoma mostly expresses tumor-specific neo-antigen...

3 Minute Read
December 20, 2017

Exploring neuritin-mediated immune suppression to ...

Study Goals: Reveal how a molecule called neuritin supports a population of immune cells that actively interferes with the killing of melanomas; determine if therapies th...

3 Minute Read
January 6, 2016

Regulation of the response to targeted inhibitors ...

Description: Melanoma of the uveal tract (a region of the eye) is the most common ocular malignancy in adults and accounts for 5% of all melanomas. According to N...

2 Minute Read

Jun 14, 2025 ET

Miles for Melanoma Denver, CO

Jul 20, 2025 ET

Miles for Melanoma Chicago, IL

Aug 03, 2025 ET

Miles for Melanoma Cleveland, OH

Aug 10, 2025 ET

Miles for Melanoma Twin Cities, MN

Aug 23, 2025 ET

Miles for Melanoma Philadelphia, PA

Sep 13, 2025 ET

Miles for Melanoma New York City, NY (Tentative)

Sep 18, 2025 ET

MRF Annual Gala – Denver

Explore Events